Pfizer's Upjohn has merged with Mylan to form Viatris
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Pfizer's Upjohn has merged with Mylan to form Viatris sits in the top decile of US sponsors by registered trial count (#186 of 15,742 sponsors by registered trial count).
Pfizer's Upjohn has merged with Mylan to form Viatris: 158 sponsored US clinical trials, none currently recruiting.
Pfizer's Upjohn has merged with Mylan to form Viatris sponsors 158 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 138 completed. 128 of these trials are in Phase 3-4 (later-stage) and 24 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.
Top-decile sponsor footprint
Pfizer's Upjohn has merged with Mylan to form Viatris ranks in the top decile of sponsors by registered trial count (#186 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
138 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
158 total, page 1 of 4
Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
NCT03768726
Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers
NCT02725112
A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
NCT02637193
Effects of Oral Sildenafil on Mortality in Adults With PAH
NCT02060487
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
NCT02072824
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
NCT02075047
Actual Use Trial of Atorvastatin Calcium 10 mg
NCT01964326
A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn
NCT01720524
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
NCT01888497
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
NCT01747915
Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
NCT01701362
Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)
NCT01302080
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
NCT01463306
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
NCT01455415
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
NCT01432236
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
NCT01474772
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
NCT01389596
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
NCT01321671
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
NCT01257529
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
NCT01270815
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
NCT01270828
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
NCT01271933
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder
NCT01302938
Once-A-Day Pregabalin For Partial Seizures
NCT01262677
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
NCT01291524
Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
NCT01256151
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
NCT01280747
Pregabalin In Adolescent Patients With Fibromyalgia
NCT01020526
Pregabalin Trial In HIV Neuropathic Pain
NCT01145417
Adolescent Fibromyalgia Study
NCT01020474
A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation
NCT01080612
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
NCT01049217
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
NCT01057693
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
NCT01078285
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
NCT00991276
Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity
NCT00990223
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
NCT00807846
Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet
NCT00950404
Pharmacokinetics Of Celecoxib Test Formulations
NCT00925106
Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia
NCT00883740
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
NCT00688545
Atorvastatin Three Year Pediatric Study
NCT00827606
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
NCT00821444
An fMRI Study Of Brain Response In Patients With Fibromyalgia
NCT00760474
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
NCT00806026
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
NCT00759174
Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.
NCT00795938
Bioequivalence Study Of Pediatric Appropriate Formulation
NCT00758004
A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects
NCT00866463
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
NCT00917579
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 5 |
| Phase 3 | 75 |
| Phase 4 | 53 |
How the Pfizer's Upjohn has merged with Mylan to form Viatris archive is shaped
158 indexed studies, none listed as recruiting (0% open); 138 completed (87%).
Phase mix: 128 late (III/IV) vs 24 early (I/II) (later-stage heavy).
Top condition: Healthy (3 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Pfizer's Upjohn has merged with Mylan to form Viatris: archived-pipeline peers nationwide
Peers matched on 158 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Pfizer's Upjohn has merged with Mylan to form Viatris sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 158 archived trials
- Galderma R&D · 158 trials · 4% recruiting
- Ann & Robert H Lurie Children's Hospital of Chicago · 159 trials · 19% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Pfizer's Upjohn has merged with Mylan to form Viatris page
158 registered trials is a research-attention snapshot, not an endorsement of Pfizer's Upjohn has merged with Mylan to form Viatris or any single study.
- None of Pfizer's Upjohn has merged with Mylan to form Viatris's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Pfizer's Upjohn has merged with Mylan to form Viatris studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pfizer's Upjohn has merged with Mylan to form Viatris pipeline card: 158 registered trials from official public datasets.Report a data error.